Addex Therapeutics Ltd header image

Addex Therapeutics Ltd

ADXN

Equity

ISIN CH0029850754 / Valor 2985075

SIX Swiss Exchange (2026-11-06)
CHF 0.021-7.96%

Addex Therapeutics Ltd
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Geneva that develops small‑molecule allosteric modulators, primarily targeting G protein‑coupled receptors and other central nervous system targets, with the aim of producing more selective therapies for neurological and neuropsychiatric disorders. Its pipeline has emphasized mGlu5 negative allosteric modulation for levodopa‑induced dyskinesia in Parkinson’s disease and related CNS indications, and the company combines proprietary discovery capabilities with external collaborations to advance candidates through preclinical and clinical development.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-65.8%1Y
-58.4%3Y
-98.4%5Y

Performance

77.8%1Y
95.4%3Y
99.2%5Y

Volatility

Market cap

3 M

Market cap (USD)

Daily traded volume (Shares)

765,087

Daily traded volume (Shares)

1 day high/low

0.058 / 0.0528

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
3.00
Daniela Gie
Germany, 19 Jun 2024
star star star star star
Hedge found is betting on that stock. (Steven Boyd's Armistice Capital ).

EQUITIES OF THE SAME SECTOR

Jubilant Pharmova Limited
Jubilant Pharmova Limited Jubilant Pharmova Limited Valor: 2477953
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%INR 938.60
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553360
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 101.00
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.70%EUR 85.26
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.57%USD 62.14
Medios AG
Medios AG Medios AG Valor: 19069483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%EUR 11.34
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.97%USD 69.74
IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.62%USD 271.83
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.82%USD 23.40
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.25%EUR 6.32
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-13.06%EUR 0.55